Patricia L Morris

Array ( [id] => 8283076 [patent_doc_number] => 08217179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Preparation method of phenylcarboxamides' [patent_app_type] => utility [patent_app_number] => 12/918133 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6303 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392279 [patent_doc_number] => 20090209592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'INHIBITORS OF THE GASTRIC H+, K+-ATPASE WITH ENHANCED THERAPEUTIC PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/413323 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29884 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209592.pdf [firstpage_image] =>[orig_patent_app_number] => 12413323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929935 [patent_doc_number] => 20110039894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/934001 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17373 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039894.pdf [firstpage_image] =>[orig_patent_app_number] => 12934001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392198 [patent_doc_number] => 20090209511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Benzofuran Derivatives' [patent_app_type] => utility [patent_app_number] => 12/382787 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49071 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209511.pdf [firstpage_image] =>[orig_patent_app_number] => 12382787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956012 [patent_doc_number] => 08501786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/936275 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38064 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618040 [patent_doc_number] => 20100324053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'TRISUBSTITUTED 1,2,4 TRIAZOLES' [patent_app_type] => utility [patent_app_number] => 12/866054 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26978 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324053.pdf [firstpage_image] =>[orig_patent_app_number] => 12866054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515708 [patent_doc_number] => 07932274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => '3-indazolyl-4-pyridylisothiazoles' [patent_app_type] => utility [patent_app_number] => 12/406139 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12897 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932274.pdf [firstpage_image] =>[orig_patent_app_number] => 12406139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055941 [patent_doc_number] => 20110112301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'CRYSTAL FORMS OF 5-[3-(2,5-DICHLORO-4, 6-DIMETHYL-1-OXY-PYRIDINE-3-YL)[1,2,4] OXADIAZOL-5-YL]-3-NITROBENZENE-1,2-DIOL' [patent_app_type] => utility [patent_app_number] => 12/933044 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8174 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112301.pdf [firstpage_image] =>[orig_patent_app_number] => 12933044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474581 [patent_doc_number] => 20090247747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'PROCESS FOR THE PREPARATION OF TIOTROPIUM BROMIDE' [patent_app_type] => utility [patent_app_number] => 12/403984 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7250 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247747.pdf [firstpage_image] =>[orig_patent_app_number] => 12403984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299869 [patent_doc_number] => 08648097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Pyridylaminoacetic acid compound' [patent_app_type] => utility [patent_app_number] => 12/922028 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84021 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944816 [patent_doc_number] => 20110105436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/921767 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 84265 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105436.pdf [firstpage_image] =>[orig_patent_app_number] => 12921767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701739 [patent_doc_number] => 08394961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Method for the preparation of dabigatran' [patent_app_type] => utility [patent_app_number] => 12/922214 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2393 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527989 [patent_doc_number] => 20090198066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'AMORPHOUS ESOMEPRAZOLE HYDRATE' [patent_app_type] => utility [patent_app_number] => 12/399514 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20090198066.pdf [firstpage_image] =>[orig_patent_app_number] => 12399514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196690 [patent_doc_number] => 20110028448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'PYRIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/920569 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20331 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028448.pdf [firstpage_image] =>[orig_patent_app_number] => 12920569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355682 [patent_doc_number] => 20090187026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Diastereomeric purification of rosuvastatin' [patent_app_type] => utility [patent_app_number] => 12/380419 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9479 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20090187026.pdf [firstpage_image] =>[orig_patent_app_number] => 12380419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127250 [patent_doc_number] => 08575200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Pyridin-2-yl derivatives as immunomodulating agents' [patent_app_type] => utility [patent_app_number] => 12/920656 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26263 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12920656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515519 [patent_doc_number] => 20090215826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'SOLID FORMS OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/388536 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8485 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215826.pdf [firstpage_image] =>[orig_patent_app_number] => 12388536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576231 [patent_doc_number] => 20090143593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'SYNTHESIS OF HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/369940 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6624 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143593.pdf [firstpage_image] =>[orig_patent_app_number] => 12369940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149892 [patent_doc_number] => 20110021487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/867560 [patent_app_country] => US [patent_app_date] => 2009-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28004 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021487.pdf [firstpage_image] =>[orig_patent_app_number] => 12867560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485881 [patent_doc_number] => 07902371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => '(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate' [patent_app_type] => utility [patent_app_number] => 12/358631 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14911 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902371.pdf [firstpage_image] =>[orig_patent_app_number] => 12358631 [rel_patent_id] =>[rel_patent_doc_number] =>)